2-氯-5-硝基苯甲酰胺 | 16588-15-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氯-5-硝基苯甲酰胺
• 英文名称: 2-chloro-5-nitro-benzamide
• 英文别名: 2-chloro-5-nitrobenzenecarboxamide；2-chloro-5-nitrobenzoic acid amide；2-Chloro-5-nitrobenzamide
• CAS: 16588-15-1
• 化学式: C₇H₅ClN₂O₃
• mdl: MFCD00088420
• 分子量: 200.581
• InChiKey: SDHXWAPVLOGAJR-UHFFFAOYSA-N

物化性质

• 熔点：
  178 °C
• 沸点：
  299.0±25.0 °C(Predicted)
• 密度：
  1.520±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  常温常压下稳定，避免与氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  88.9
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2924299090
• 储存条件：
  常温下请将物品存放在密闭、避光、通风和干燥的地方。

SDS

Name:	2-Chloro-5-nitrobenzamide 97% Material Safety Data Sheet
Synonym:
CAS:	16588-15-1

Section 1 - Chemical Product MSDS Name:2-Chloro-5-nitrobenzamide 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
16588-15-1	2-Chloro-5-nitrobenzamide	97%	unlisted

Hazard Symbols: XN
Risk Phrases: 22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 16588-15-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: pale yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 183 - 185 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H5ClN2O3
Molecular Weight: 201

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Acids, bases, oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 16588-15-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Chloro-5-nitrobenzamide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 16588-15-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 16588-15-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 16588-15-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  2-氯-5-硝基苯甲酰氯	2-chloro-5-nitrobenzoylchloride	25784-91-2	C7H3Cl2NO3	220.012
  2-氯-5-硝基苯甲酸	2-chloro-5-nitrobenzoic acid	2516-96-3	C7H4ClNO4	201.566
  2-氯-5-硝基苯甲腈	4-chloro-3-cyanonitrobenzene	16588-02-6	C7H3ClN2O2	182.566

• 下游产品

  中文名称	英文名称	CAS号	化学式	分子量
  2-氯-N-甲基-5-硝基苯甲酰胺	2-chloro-5-nitro-N-methylbenzamide	85469-93-8	C8H7ClN2O3	214.608
  ——	2-chloro-5-nitrobenzoyl isocyanate	1143020-44-3	C8H3ClN2O4	226.576
  ——	N-ethyl-2-chloro-5-nitrobenzamide	117054-83-8	C9H9ClN2O3	228.635
  ——	2-chloro-5-nitro-N-(n-propyl)benzamide	130674-22-5	C10H11ClN2O3	242.662
  ——	1,2-bis-(2-chloro-5-nitro-benzoylamino)-ethane	——	C16H12Cl2N4O6	427.2
  ——	2-chloro-5-nitro-N,N-diethylbenzamide	67272-98-4	C11H13ClN2O3	256.689
  5-氨基-2-氯苯甲酰胺	5-amino-2-chlorobenzamide	111362-50-6	C7H7ClN2O	170.598
  2-氯-5-硝基苯甲酰氯	2-chloro-5-nitrobenzoylchloride	25784-91-2	C7H3Cl2NO3	220.012
  2-氯-5-硝基苯甲酸	2-chloro-5-nitrobenzoic acid	2516-96-3	C7H4ClNO4	201.566
  2-氨基-5-硝基苯酰胺	2-amino-5-nitrobenzamide	16313-65-8	C7H7N3O3	181.151

反应信息

• 作为反应物：
  描述：

  2-氯-5-硝基苯甲酰胺 在 苯磺酰氯 作用下， 以 DMF (N,N-dimethyl-formamide) 、 乙醇 、 甲苯 为溶剂， 反应 4.0h， 生成 2-cyano-4-nitro-N,N-diethylaniline
  参考文献：
  名称：

  AMIDE COMPOUNDS AND MEDICINAL USE THEREOF

  摘要：

  公开号：

  EP1176140B1
• 作为产物：
  描述：

  2-氯-5-硝基苯甲腈 在 sodium hydroxide 、 双氧水 作用下， 生成 2-氯-5-硝基苯甲酰胺
  参考文献：
  名称：

  Blanksma, Recueil des Travaux Chimiques des Pays-Bas, 1946, vol. 65, p. 207,210

  摘要：

  DOI：

文献信息

• Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur
  申请人：A. H. Robins Company, Inc.

  公开号：US04705853A1

  公开（公告）日：1987-11-10

  Aromatic azepinones and thiones having the formula ##STR1## wherein; A is benzene, naphthalene, quinoline or pyridine; B is oxygen or sulfur; E is oxygen, sulfur or ##STR2## n is 1, 2 or 3; Z is an amino or a heterocyclic nitrogen-containing radical; R is hydrogen, loweralkyl, cycloalkyl or phenylloweralkyl; Y is halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracetylamino, trifluoromethyl, phenyl or phenyl substituted by one to three Y' radicals selected from halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracylamino or trifluoromethyl; and having antihistaminic utility, a process for the preparation thereof and chemical intermediates therefor are disclosed.

  芳香族氮杂七元酮和硫醚的化学式为##STR1##其中；A为苯、萘、喹啉或吡啶；B为氧或硫；E为氧、硫或##STR2##n为1、2或3；Z为氨基或含氮杂环的基团；R为氢、较低烷基、环烷基或苯基较低烷基；Y为卤素、较低烷基、较低烷氧基、二较低烷基氨基、硝基、氨基、较低乙酰氨基、三氟甲基、苯基或被从卤素、较低烷基、较低烷氧基、二较低烷基氨基、硝基、氨基、较低酰胺基或三氟甲基中选择的一个至三个Y'基团取代的苯基；具有抗组胺作用，公开了其制备方法和化学中间体。
• Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells
  作者：Brian D. Palmer、William R. Wilson、Stephen Cliffe、William A. Denny

  DOI：10.1021/jm00095a018

  日期：1992.8

  Nitroaniline mustards have potential as hypoxia-selective cytotoxic agents, with reductive metabolism activating the nitrogen mustard by converting the electron-withdrawing nitro group to an electron-donating hydroxylamine or amine. However, the parent compounds have poor aqueous solubility, and their potencies are limited by low reduction potentials (E1/2 ca. -600 mV versus the normal hydrogen electrode)

  硝基苯胺芥子作为低氧选择性细胞毒剂具有潜力，其还原性代谢通过将吸电子硝基转化为供电子羟胺或胺来激活氮芥。然而，母体化合物的水溶性差，并且它们的效能受到低还原电位（相对于正常氢电极的E1 / 2约-600mV）和相应的缓慢的硝基还原速率的限制。为了解决这些局限性，制备了一系列通过吸电子羧酰胺基团连接的带有亲水性侧链的4-硝基苯胺芥菜，并评估了其对中国仓鼠细胞系的低氧选择性细胞毒性。N-[（N，N-二甲基氨基）乙基]羧酰胺衍生物具有优异的水溶性和改善的细胞毒性，但是它们的还原潜力虽然比非羧酰胺化合物高，但仍然很低，并且观察到的对缺氧细胞的选择性很小。还制备了一系列的2，4-二硝基苯胺芥末羧酰胺。这些化合物的还原电位在所需范围内（通过循环伏安法测得的E1 / 2约为-450 mV），并且对缺氧的毒性比需氧的UV4细胞高。选择性最高的化合物是5- [N，N-双（2-氯乙基）氨基] -2,4-二硝基苯甲酰胺（20，SN
• NOVEL 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES HAVING BOTH AROMATIC AND HALOGENIC SUBSTITUENTS
  申请人：Lori Franco

  公开号：US20140057911A1

  公开（公告）日：2014-02-27

  Certain 4,6-disubstituted aminopyrimidine derivatives having both aromatic and halogenic substituents.

  某些具有芳香族和卤素取代基的4,6-二取代氨基嘧啶衍生物。
• Isothiazolones
  申请人：Warner-Lambert Company

  公开号：US05620997A1

  公开（公告）日：1997-04-15

  Isothiazolones having the general structure ##STR1## where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R.sup.1 and R.sup.2 are substituent groups such as alkyl, alkoxy, hydroxy, nitro, cyano, amino, and carboxy; and R.sup.5 is alkyl, cycloalkyl, phenyl, and Het. The isothiazolones are useful as anti-retroviral agents, anti-inflammatory agents, and anti-atherosclerotic agents.

  异噻唑酮具有一般结构##STR1##其中A是一个可以包含最多3个来自O、S和N的杂原子的单环或双环环；R.sup.1和R.sup.2是取代基，如烷基、烷氧基、羟基、硝基、氰基、氨基和羧基；R.sup.5是烷基、环烷基、苯基和Het。异噻唑酮可用作抗逆转录病毒药物、抗炎药物和抗动脉粥样硬化药物。
• A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: The 2,2′-dithiobisbenzamides
  作者：John M. Domagala、John P. Bader、Rocco D. Gogliotti、Joseph P. Sanchez、Michael A. Stier、Yuntao Song、J.V.N. Vara Prasad、Peter J. Tummino、Jeffrey Scholten、Patricia Harvey、Tod Holler、Steve Gracheck、Donald Hupe、William G. Rice、Robert Schultz

  DOI：10.1016/s0968-0896(96)00269-6

  日期：1997.3

  for anti-HIV-1 activity, cytotoxicity, and their ability to extrude zinc from the zinc fingers for NCp7. The structure-activity relationships demonstrated that the ability to extrude zinc from NCp7 resided in the 2,2'-dithiobisbenzamide core structure. The 3,3' and the 4,4' isomers were inactive. While many analogs based upon the core structure retained the zinc extrusion activity, the best overall

  作为美国国家癌症研究所药物筛选计划的一部分，已经鉴定出了一类新的对人类免疫缺陷病毒HIV-1有活性的抗逆转录病毒药，并提出了HIV-1核衣壳蛋白NCp7作为抗病毒作用的靶标。2,2'-二硫代双-[4'-（氨磺酰基）苯甲酰苯胺]（3x）和2,2'-二硫代双（5-乙酰氨基）苯甲酰胺（10）代表了原型铅结构。制备了各种2,2'-二硫代双苯甲酰胺，并测试了它们的抗HIV-1活性，细胞毒性以及从NCf7的锌指中挤出锌的能力。结构-活性关系表明，从NCp7挤出锌的能力存在于2,2'-二硫代双苯甲酰胺核心结构中。3,3'和4,4'异构体没有活性。虽然许多基于核心结构的类似物保留了锌的挤出活性，但只有在具有羧酸，羧酰胺或苯磺酰胺官能团的狭窄衍生物中才发现最佳的总体抗HIV-1活性。这些功能组与降低NCp7的抗病毒效力或活性相比，对于降低细胞毒性而言更为重要。所有具有抗病毒活性的化合物也从NCp7中挤出锌。